Picture of Arcutis Biotherapeutics logo

ARQT Arcutis Biotherapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual cashflow statement for Arcutis Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-42-136-206-311-262
Depreciation
Amortisation
Non-Cash Items0.5978.3927.76337.1
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-1.514.13.62-10.2-23.5
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-42.8-113-175-258-247
Capital Expenditures-0.295-0.321-0.995-23.3-0.428
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-26-182-75-63.9181
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-26.3-182-76-87.2180
Financing Cash Flow Items-1.40-1.64-2.190
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities93.1298282302101
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash23.93.2931.4-43.134.4